Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014, Article ID 145394, 5 pages
http://dx.doi.org/10.1155/2014/145394
Case Report

A Case of Gingival Candidiasis with Bone Destruction on Gastric Cancer Patient Receiving Cytotoxic Chemotherapy

1Department of Internal Medicine, Konyang University Hospital, Gasuwon-dong, Seo-gu, Daejeon 302-718, Republic of Korea
2Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
3Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
4Yonsei Cancer Center, Yonsei Cancer Research Institute, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
5Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
6Department of Oral Pathology, Yonsei University College of Dentistry, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea

Received 20 October 2014; Revised 13 December 2014; Accepted 16 December 2014; Published 29 December 2014

Academic Editor: Raffaele Palmirotta

Copyright © 2014 Seungtaek Lim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Kelley and J. M. Duggan, “Gastric cancer epidemiology and risk factors,” Journal of Clinical Epidemiology, vol. 56, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. H. Kim, “Chemotherapy for advanced gastric cancer: slow but further progress,” Cancer Research and Treatment, vol. 37, no. 2, pp. 79–86, 2005. View at Publisher · View at Google Scholar
  3. B. Glimelius, K. Ekström, K. Hoffman et al., “Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer,” Annals of Oncology, vol. 8, no. 2, pp. 163–168, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. Wagner, W. Grothe, J. Haerting, G. Kleber, A. Grothey, and W. E. Fleig, “Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2903–2909, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. McGowan, “Chemotherapy-induced oral dysfunction: a literature review,” British Journal of Nursing, vol. 17, no. 22, pp. 1422–1426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Koizumi, H. Narahara, T. Hara et al., “S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial,” The Lancet Oncology, vol. 9, no. 3, pp. 215–221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Dreizen, G. P. Bodey, and M. Valdivieso, “Chemotherapy-associated oral infections in adults with solid tumors,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 55, no. 2, pp. 113–120, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sen, S. Mandal, S. Bhattacharya, S. Halder, and P. Bhaumik, “Oral manifestations in human immunodeficiency virus infected patients,” Indian Journal of Dermatology, vol. 55, no. 1, pp. 116–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Slots, T. E. Rams, and M. A. Listgarten, “Yeasts, enteric rods and pseudomonads in the subgingival flora of severe adult periodontitis,” Oral Microbiology and Immunology, vol. 3, no. 2, pp. 47–52, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Holmstrup, “Non-plaque-induced gingival lesions,” Annals of Periodontology, vol. 4, no. 1, pp. 20–31, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Glick, B. C. Muzyka, D. Lurie, and L. M. Salkin, “Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 77, no. 4, pp. 344–349, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. D. F. Kinane and G. J. Marshall, “Periodontal manifestations of systemic disease,” Australian Dental Journal, vol. 46, no. 1, pp. 2–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Kim, M. Emi, and K. Tanabe, “Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity,” Immunology, vol. 119, no. 2, pp. 254–264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Keefe, M. M. Schubert, L. S. Elting et al., “Updated clinical practice guidelines for the prevention and treatment of mucositis,” Cancer, vol. 109, no. 5, pp. 820–831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Ogawa, T. Ueno, K. Kato et al., “A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients,” International Journal of Clinical Oncology, vol. 18, no. 6, pp. 1020–1024, 2013. View at Publisher · View at Google Scholar · View at Scopus